Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision stamp was updated from v3.6.4 to v3.6.5, indicating a frontend update to this ClinicalTrials.gov page.SummaryDifference0.0%

- Check23 days agoChange DetectedNo additions or deletions were found on the page. The current study details remain unchanged.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small system or UI update to the study record display.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating deployment of site updates; the study page content remains unchanged.SummaryDifference0.0%

- Check59 days agoChange DetectedUpdated the page revision tag from v3.6.0 to v3.6.2, indicating a new build of the page. This change affects only metadata and does not alter visible content or interactions.SummaryDifference0.0%

- Check73 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' signaling that enrollment for this study has ended. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and applies minor formatting changes to the Intervention/Treatment label, along with a new site revision tag v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.